Insider Transactions in Q1 2024 at Avanos Medical, Inc. (AVNS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,596
-2.02%
|
$68,324
$19.09 P/Share
|
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,531
+2.74%
|
-
|
|
Mar 18
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,005
-2.92%
|
$171,095
$19.09 P/Share
|
|
Mar 18
2024
|
Michael Greiner Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,219
+2.64%
|
-
|
|
Mar 18
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,765
-3.77%
|
$641,535
$19.09 P/Share
|
|
Mar 18
2024
|
Joseph Fralin Woody Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,821
+3.37%
|
-
|
|
Mar 14
2024
|
Michael Greiner Interim CEO |
SELL
Open market or private sale
|
Direct |
8,000
-0.85%
|
$152,000
$19.14 P/Share
|
|
Mar 11
2024
|
Julie Ann Shimer Director |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$9,500
$19.85 P/Share
|
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,618
-2.91%
|
$49,742
$19.0 P/Share
|
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,573
+28.94%
|
$694,887
$19.14 P/Share
|
|
Mar 06
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,118
-3.11%
|
$97,242
$19.0 P/Share
|
|
Mar 06
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,471
+25.88%
|
$1,091,949
$19.14 P/Share
|
|
Mar 06
2024
|
Sudhakar Varshney SVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,394
-4.41%
|
$26,486
$19.0 P/Share
|
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,951
-2.67%
|
$37,069
$19.0 P/Share
|
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,695
+29.62%
|
$583,205
$19.14 P/Share
|
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-2.08%
|
$2,679
$19.0 P/Share
|
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,829
+21.23%
|
$34,751
$19.14 P/Share
|
|
Mar 06
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,868
-1.98%
|
$168,492
$19.0 P/Share
|
|
Mar 06
2024
|
Joseph Fralin Woody Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
137,147
+23.48%
|
$2,605,793
$19.14 P/Share
|
|
Mar 05
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-2.79%
|
$27,036
$18.76 P/Share
|
|
Mar 05
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,991
-4.48%
|
$89,838
$18.76 P/Share
|
|
Mar 05
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,190
-4.93%
|
$39,420
$18.76 P/Share
|
|
Mar 05
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-2.66%
|
$151,758
$18.76 P/Share
|
|
Mar 05
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.68%
|
$576
$18.76 P/Share
|
|
Jan 03
2024
|
John P Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
|
Jan 03
2024
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+12.33%
|
-
|
|
Jan 03
2024
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
|
Jan 03
2024
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+13.29%
|
-
|
|
Jan 03
2024
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+37.76%
|
-
|